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Identity 




Major mRNA species of 4-5 kb and a less prominent 
species of 6-8 kb; 2946 bp open reading frame. 
Protein 
Description 
982 amino acids; 120 kDa; the overall structure of 
CBLb is very close to the sructure of CBL: the 
evolutionarily conserved aminoterminal region of CBL 
is composed of three interacting domains: a four-helix 
bundle (4H), an EF-hand calcium binding domain, and
a divergent SH2 domain; the three domains together 
form an integrated phosphoprotein -recognition 
module; this aminoterminal region is followed by a 
central Ring finger with a Cys3HisCys4 motif and an 
aminoterminal region with multiple proline-rich 
sequences, a putative leucine zipper and several 
potential tyrosine phosphorylation sites; two 
alternatively spliced mRNA code form CBLb proteins 
lacking the leucine zipper. 
Expression 
Expression of CBLb was seen in several human adult 
tissues including lung, spleen and testis but not i 
human brain, liver, pancreas, salivary gland or skeletal  
muscle; expression was also detected in fetal brain and 
liver, in hematopoietic cell lines and in normal and 




Regulation of signal transduction; CBLb has been 
shown to inhibit c-Jun terminal kinase (JNK) activation 
mediated by the (VAV oncoprotein and EGF receptor 
(EGFR) signaling; in contrast, a direct interaction 
between CBLb and the kinase ZAP-70 induces a 
positive signal in T cells. 
Mutations 
Note 
No genomic alterations described to date. 
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